In 2019 funding will be made available for 8 RIMLS Junior Researcher projects. The call for these PhD grants is now open.
The funding will be made available for junior researcher projects. These positions will be distributed over the three research institutes based on the number of (j)PIs in these institutes. The calls will be organized by the three research institutes separately.
The criteria for application and the application form can be found via this link.
Procedure:An external representative jury will be installed to review the projects and CV’s of the main applicants. The jury will rank projects according to:
- Novelty, innovation & impact
- Scientific quality
- Past performance of the main applicant
- Relevance to the Theme and RIMLS
- International nature of the project
- Final assessment
Submission of proposal : 27 May 2018 to firstname.lastname@example.org
Review to applicants : 22 June 2018 to applicant
Rebuttal : 1 July 2018 to email@example.com
Final decision to applicants: October 2018 to applicant
Related news items
Handbook of biomarkers and precision medicine a new publication by Alain van Gool12 July 2019
Alain van Gool published a new handbook on biomarkers and applications in (pre)clinical drug development for precision medicine.read more
Successful Summer School by CMBI, TML and Human Genetics8 July 2019
CMBI, TML and Human Genetics organized a successful Summer School on 'Integrative X-omics Analyses Empowering Personalized Healthcare'.read more
Summer greetings from René Bindels5 July 2019
In this last newsletter before the summer break and before I wish you all a happy holiday, I would like to briefly summarize the first half of 2019 and especially look ahead to the interesting activities that will take place in the second half of the year.read more
Prostate cancer theranostics imaging, surgical guidance, and targeted photodynamic therapy5 July 2019
In Theranostics, Mark Rijpkema and colleagues present the development of a novel multimodal tracer that targets both preoperative imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing prostate cancer.read more